Xenetic biosciences, inc. (XBIO)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Jun'14Mar'14Dec'13Nov'13Aug'13May'13Feb'13Dec'12Nov'12Aug'12May'12Feb'12Aug'11
ASSETS
Current assets:
Cash

9,367

10,367

12,044

1,034

2,018

571

1,612

3,258

3,866

5,533

694

2,331

4,323

4,048

211

240

1,605

132

1,246

301

936

2,507

7,614

10,857

4,839

40

53

62

44

11,136

32

32

33

11

10

Restricted cash

-

-

-

-

-

66

-

-

-

66

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

0

0

66

-

66

66

66

-

66

66

66

66

66

66

66

66

-

-

-

66

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

-

-

-

-

-

-

-

-

-

-

42

0

0

3,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepayment on acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

3,744

3,744

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

66

66

66

-

66

66

66

-

-

-

-

-

-

-

-

-

-

Accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

4

10

29

43

130

132

99

72

36

0

Other receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1

81

-

182

245

256

-

-

-

-

81

-

-

-

-

-

Prepaid expenses and other

1,310

722

876

1,354

1,116

555

610

675

343

285

1,245

1,432

1,820

1,224

930

171

236

247

195

129

87

204

423

329

168

-

-

-

-

195

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8

9

9

-

-

-

0

-

-

-

Total current assets

10,677

11,089

12,921

2,388

3,201

1,193

2,289

4,000

4,276

5,884

2,049

3,830

6,210

8,338

1,209

478

5,652

4,190

1,507

498

1,171

2,777

8,286

11,498

5,329

53

72

100

88

11,544

164

131

105

47

10

Property and equipment, net

0

0

1

2

3

4

8

16

22

27

32

37

40

42

49

58

67

62

74

82

89

119

156

148

152

395

413

177

182

122

187

193

198

203

212

Goodwill

-

-

0

3,283

3,283

3,283

3,283

3,283

3,283

3,283

3,283

3,283

3,283

3,283

3,283

3,283

3,283

3,283

3,283

3,283

3,303

3,465

3,801

3,697

3,665

-

-

-

-

3,592

-

-

-

-

-

Indefinite-lived intangible assets

9,243

9,243

9,243

9,243

9,243

9,243

9,243

9,243

9,243

9,243

9,243

9,243

9,243

9,243

9,243

9,243

9,243

9,243

9,243

9,243

9,299

9,754

10,702

10,409

10,318

-

-

-

-

10,112

-

-

-

-

-

Other assets

704

1,213

709

715

724

705

709

714

718

724

31

43

54

66

81

97

113

129

145

162

178

199

105

112

-

-

-

-

-

-

-

-

-

-

-

Total assets

20,625

21,546

22,875

15,633

16,456

14,431

15,533

17,257

17,543

19,163

14,639

16,438

18,831

20,973

13,866

13,160

18,360

16,908

14,253

13,269

14,041

16,316

23,052

25,868

19,465

448

486

277

270

25,371

351

324

303

251

222

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

1,051

931

1,158

1,023

1,040

934

512

746

896

786

1,026

1,013

1,368

1,006

2,172

2,021

1,629

1,788

1,484

1,756

1,360

852

589

592

942

-

-

-

-

119

-

-

-

-

-

Accrued expenses

-

-

-

-

-

-

800

796

826

1,135

1,113

920

605

838

1,488

1,607

1,536

1,487

1,381

862

935

1,409

792

1,092

1,826

-

-

-

-

456

-

-

-

-

-

Other current liabilities

-

-

-

-

-

-

6

11

16

-

21

67

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Hybrid debt instruments, net of accumulated amortization of $0 and $108,527 at December 31, 2016 and 2015, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,135

0

7,003

3,652

2,814

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued payroll taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

61

299

84

-

-

-

-

86

-

-

-

-

-

Accrued expenses and other current liabilities

-

-

538

1,293

965

-

-

-

-

21

-

-

20

20

19

19

19

19

33

454

154

41

44

34

55

-

-

-

-

53

-

-

-

-

-

Loans due to related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

152

152

157

395

395

395

395

395

626

681

681

-

-

-

-

682

-

-

-

-

-

Accrued expenses and other current liabilities

456

484

-

-

-

665

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

308

429

147

130

-

229

190

130

76

7

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

32

26

23

19

-

16

13

10

7

0

Total current liabilities

1,507

1,415

1,697

2,317

2,006

1,599

1,319

1,554

1,739

1,943

2,161

2,001

1,994

1,865

4,968

3,800

10,346

7,342

6,109

3,469

2,844

2,698

2,115

2,699

3,590

340

456

170

150

1,399

246

204

140

83

7

Deferred tax liability

2,918

2,918

2,918

2,918

2,918

2,918

2,918

2,918

2,918

2,918

2,918

2,918

2,918

2,918

2,918

2,918

2,918

2,918

2,918

2,918

2,936

3,080

3,379

3,286

3,257

-

-

-

-

3,192

-

-

-

-

-

Other liabilities

-

-

-

6

13

-

-

-

-

-

4

10

15

19

24

29

34

38

43

47

52

56

64

70

-

-

-

-

-

-

-

-

-

-

-

Long-term debt:

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

212

212

-

212

212

212

212

212

Line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

160

0

-

-

-

-

-

-

-

-

Note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

212

212

-

-

-

-

-

-

-

-

Total long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

372

212

-

-

-

-

-

-

-

-

Total liabilities

4,425

4,333

4,615

5,242

4,937

4,518

4,238

4,472

4,657

4,862

5,084

4,929

4,927

4,804

7,912

6,748

13,299

10,299

9,070

6,435

5,832

5,835

5,559

6,057

6,847

713

668

383

363

4,592

459

417

-

-

220

Commitments (Note 10)

-

-

-

-

-

-

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

0

-

-

-

-

-

Stockholders' equity:
Preferred stock, 10,000,000 shares authorized

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-

0

0

0

0

0

Common stock, $0.001 par value; 12,500,000 shares authorized as of March 31, 2020 and December 31, 2019; 6,311,906 and 6,092,432 shares issued as of March 31, 2020 and December 31, 2019, respectively; 6,284,915 and 6,065,441 shares outstanding as of March 31, 2020 and December 31, 2019, respectively

6

6

5

0

10

0

9

9

9

9

9

9

8

8

8

9

162

4

150

1,499

1,499

149

1,467

1,467

1,305

135

135

135

135

1,305

13

135

13

10

10

Additional paid in capital

188,405

188,240

188,116

171,352

171,093

168,170

167,904

167,581

165,656

165,249

164,948

164,646

164,122

163,522

152,865

150,905

101,629

99,763

94,564

89,548

89,458

90,660

88,022

87,979

73,999

0

0

0

0

73,566

31

0

31

0

0

Accumulated deficit

-167,188

-166,008

-164,838

-155,938

-154,560

-153,233

-151,594

-149,781

-147,755

-145,933

-150,378

-148,122

-145,203

-142,338

-141,946

-139,474

-91,703

-88,131

-84,504

-79,180

-78,055

-75,624

-68,139

-65,380

-58,306

-399

-317

-

-

-49,727

-

-227

-

-

-

Accumulated other comprehensive income

253

253

253

253

253

253

253

253

253

253

253

253

253

253

253

253

253

253

253

248

587

575

1,423

1,026

900

-

-

-

-

915

-

-

-

-

-

Treasury stock

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

5,281

-

-

-

-

5,281

-

-

-

-

-

Deficit accumulated during development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

240

227

-

152

-

-94

-55

8

Total stockholders' equity

16,199

17,213

18,259

10,390

11,518

9,912

11,295

12,784

12,885

14,301

9,554

11,508

13,903

16,169

5,953

6,412

5,060

6,608

5,183

6,834

8,208

10,480

17,493

19,811

12,617

-264

-182

-105

-92

20,778

-107

-92

-49

-45

1

Total liabilities and stockholders' equity

20,625

21,546

22,875

15,633

16,456

14,431

15,533

17,257

17,543

19,163

14,639

16,438

18,831

20,973

13,866

13,160

18,360

16,908

14,253

13,269

14,041

16,316

23,052

25,868

19,465

448

486

277

270

25,371

351

324

303

251

222

Series B [Member]
Preferred stock, 10,000,000 shares authorized

-

-

1

1

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series A [Member]
Preferred stock, 10,000,000 shares authorized

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred Class A [Member]
Preferred stock, 10,000,000 shares authorized

0

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred Class B [Member]
Preferred stock, 10,000,000 shares authorized

1

1

-

-

-

1

-

-

-

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-